Philadelphias

$1.1 Billion Risperdal Settlement a Landmark Victory for Plaintiffs in Philadelphia’s Mass Tort History

by

Philadelphia, PA — The sprawling legal battle over Risperdal, once involving over 7,000 cases, has largely concluded with settlements that encompass a total of up to $1.1 billion. The litigation revolved around allegations that the drug, often prescribed off-label, led to the development of gynecomastia in young men and boys, a condition characterized by the growth of breast tissue. The resolution of these cases marked a significant moment in the city’s Complex Litigation Center, noted for handling one of the largest mass torts in its history. This litigation was notable not only for its size … Read more

Philadelphia’s Anapol Weiss Merges with D.C.’s Top Legal Minds, Expanding Its Reach in Personal Injury Law

by

Philadelphia, PA – Anapol Weiss, a law firm specializing in mass torts and personal injury, has officially expanded its operations to Washington, D.C., incorporating a team of five skilled attorneys led by Alexandra Walsh, a notable former partner and founder at Wilkinson Stekloff LLP. This strategic move brings the firm’s deep legal expertise and client-focused approach into the heart of the nation’s capital. The integration of a seasoned legal team into Anapol Weiss marks a significant step in the firm’s growth strategy, enhancing its capabilities and reach in handling complex legal challenges across different jurisdictions. … Read more

Philadelphia’s Risperdal Litigation Nears End with Monumental $1.1 Billion Settlement Agreement

by

Philadelphia, PA — In what marks a significant resolution, nearly all lawsuits in Philadelphia involving the antipsychotic drug Risperdal have been settled for up to $1.1 billion. This settlement addresses claims that the drug, produced by Johnson & Johnson’s subsidiary Janssen Pharmaceuticals, led to adverse effects such as gynecomastia, a condition characterized by breast tissue enlargement in males. The legal battles, accumulating over years, primarily involved male plaintiffs who alleged that Risperdal, prescribed to treat schizophrenia and bipolar disorder, caused them to develop breasts after taking the medication. Many of the lawsuits also claimed that … Read more

Veteran Litigator Joins Motley Rice, Aims to Bolster Philadelphia’s Defense Against Corporate Negligence

by

Mount Pleasant, SC – Motley Rice LLC, a Mount Pleasant-based law firm specializing in class actions and multi-litigation practices, recently enhanced their team by hiring experienced litigator Mike Daly. Recognized for his extensive experience in handling mass torts, Daly joins the firm’s Philadelphia office committed to fighting corporate malfeasance through a focus on hazardous pharmaceuticals, defective medical devices, and environmental dangers including asbestos exposure. Daly, who previously cemented his reputation at Pogust Goodhead, explained in an interview the distinction between class action lawsuits and mass torts. Whereas class actions involve individuals representing a larger group, … Read more